Hav­ing ce­ment­ed its name in long-read se­quenc­ing, PacBio takes a stab at Il­lu­mi­na with new short-read tech

Pa­cif­ic Bio­sciences, or PacBio for short, made its name in long-read DNA se­quenc­ing — the tech­nol­o­gy re­cent­ly used to se­quence the en­tire hu­man genome — fill­ing in a niche mar­ket where typ­i­cal short-read DNA se­quencers, like the ones on which Il­lu­mi­na built its dom­i­nance, could not go. But now, PacBio wants to take on Il­lu­mi­na di­rect­ly.

Tues­day evening, PacBio an­nounced plans for a short-read se­quencer known as On­so. First, the se­quencer will be be­ta-test­ed by sci­en­tists at The Broad In­sti­tute, Corte­va Agri­science and Weill Cor­nell Med­i­cine, af­ter which PacBio ex­pects to launch its new short-read ma­chines in the first half of next year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.